anti-MMP1 RNAi sd-rxRNA (Phio Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Nameanti-MMP1 RNAi sd-rxRNA (Phio Pharmaceuticals)

Drug Alias Nameanti-MMP1 RNAi sd-rxRNA (RXi Pharmaceuticals)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionMatrix metalloproteinase-1 inhibitors

TargetsMatrix metalloproteinase-1

Therapy Area/IndicationsHealthy AgingWounds and InjuriesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPhio Pharmaceuticals Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPhio Pharmaceuticals Corp

Active IndicationsN/A

Inactive IndicationsHealthy AgingWounds and InjuriesNeoplasms

Other Information

ATC CodeN/A